Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1050982 | Benzalkonium Bromide (C12) | 150 mg |
| USP-1162648 | Beta-Damascone | 3 x 0,5 mL |
| USP-1073423 | Biphenyl | 500 mg |
| USP-1078573 | Buspirone Related Compound A (75 mg x 2) - (2-(Piperazin-1-yl)pyrimidine) | 2 x 75 mg |
| USP-1078813 | Buspirone Related Compound G (50 mg) - (1,4-Di(pyrimidin-2-yl)piperazine) | 50 mg |
| USP-1078642 | Buspirone Related Compound K (50 mg) - (8-azaspiro[4.5]decane-7,9-dione) | 50 mg |
| USP-1078824 | Buspirone Related Compound L (75 mg x 2) - (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione) | 2 x 75 mg |
| USP-1078835 | Buspirone Related Compound N (50 mg) - (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione) | 50 mg |
| USP-1082967 | Butyl Hexanoate | 3 x 500 mg |
| USP-1082640 | Butyllsothiocyanate | 1 mL |
| USP-1082672 | Butyl Valerate | 1 mL |
| USP-1087483 | Calycosin 7-O-beta-D-Glucopyranoside (50 mg) - (3-(3-Hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside) | 50 mg |
| USP-1098253 | Cefuroxime Axetil E-isomers (15 mg) - (1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate) | 15 mg |
| USP-1144951 | Cloxacillin Related Compound D (15 mg) - (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid) | 15 mg |
| USP-1148250 | Color Related Compound 007 (20 mg) - (1-[(4-methylphenyl)azo]-2-naphthalenol) | 20 mg |
| USP-1162637 | Delta-Damascone | 3 x 0,5 mL |
| USP-1189053 | Dicloxacillin Related Compound D (15 mg) - (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid) | 15 mg |
| USP-1225601 | Doxercalciferol | 2 x 20 mg |
| USP-1265843 | Ethyl Linoleate | 1 mL |
| USP-1266609 | Ethyl Oleate | 1 mL |
| USP-1267102 | Ethyl Stearate | 100 mg |
| USP-1277037 | Fluorescein Related Compound C (25 mg) - (2-(2,4-Dihydroxybenzoyl)benzoic acid) | 25 mg |
| USP-1295764 | Glyceryl Monocaprylate (Type II) | 300 mg |
| USP-1295775 | Glyceryl Monocaprylocaprate (Type I) | 300 mg |
| USP-1335596 | Ibuprofen Related Compound J (25 mg) - (2-(4-Isobutyrylphenyl)propanoic acid) | 25 mg |
| USP-1347824 | Isobutyl Heptanoate | 5 x 0,5 mL |
| USP-1347835 | Isobutyl isobutyrate | 5 x 0,5 mL |
| USP-1304130 | Low Molecular Weight Heparin for Boron Analysis | 300 mg |
| USP-1445550 | Monoclonal IgG System Suitability (COLD SHIPMENT REQUIRED) | 2 mg |
| USP-1448989 | Mycophenolate Sodium | 200 mg |
| USP-1478232 | Oligosaccharide System Suitability Mixture C | 20 |
| USP-1478243 | Oligosaccharide System Suitability Mixture D | 20 |
| USP-1491795 | Paliperidone Resolution Mixture | 20 mg |
| USP-1492211 | Palonosetron Enantiomer (15 mg) - ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 15 mg |
| USP-1492222 | Palonosetron Related Compound A (15 mg) - ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide) | 15 mg |
| USP-1492233 | Palonosetron Related Compound B (15 mg) - ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide) | 15 mg |
| USP-1492244 | Palonosetron Related Compound C (15 mg) - ((3aS)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 15 mg |
| USP-1492266 | Palonosetron Related Compound E (15 mg) - (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 15 mg |
| USP-1510914 | Perindopril Related Compound C (20 mg) - ((S)-2-[(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]pentanoic acid) | 20 mg |
| USP-1535899 | Phthalic Acid | 50 mg |
| USP-1545023 | Plastic Additive 11 (100 mg) - (Copolymer of Dimethyl Succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol)) | 100 mg |
| USP-1545034 | Plastic Additive 12 (100 mg) - (Oleamide) | 100 mg |
| USP-1545056 | Plastic Additive 14 (100 mg) - (Di(2-ethylhexyl) phthalate) | 100 mg |
| USP-1545078 | Plastic Additive 16 (100 mg) - (Epoxidized Linseed Oil) | 100 mg |
| USP-1612903 | Sitagliptin Phosphate | 200 mg |
| USP-1613881 | Sodium D,L-Malate | 50 mg |
| USP-1614159 | Sodium Hyaluronate for IR Identification | 250 mg |
| USP-1615138 | Sodium Trifluoroacetate | 500 mg |
| USP-1700013 | Trypsin Recombinant Porcine (COLD SHIPMENT REQUIRED) | 2 x 1 mL |
| USP-1711010 | Vardenafil Hydrochloride | 200 mg |
| USP-1727075 | Zolmitriptan Related Compound F (25 mg) - (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole}) | 25 mg |
| USP-1727086 | Zolmitriptan Related Compound G (25 mg) - ((S)-4-(4-Aminobenzyl)oxazolidin-2-one) | 25 mg |
| USP-1724383 | Zaleplon Related Compound C (25 mg) - (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide) | 25 mg |
| USP-1613429 | Sodium Acetate Trihydrate | 1 g |
| USP-1366013 | Lidocaine hydrochloride monohydrate | 150 mg |
| USP-1012156 | Aflatoxins (International Restricted Sales Item)(COLD SHIPMENT REQUIRED) | 1 mL |
| USP-1040504 | Antithrombin 111 Human | 4,38 IU |
| USP-1086141 | Calcipotriene | 200 mg |
| USP-1133569 | Chondroitin Sulfate Sodium, Shark | 300 mg |
| USP-1148238 | Color Related Compound 005 - 3-Hydroxy-2-naphthalenecarboxylic acid | 20 mg |
| USP-1270457 | High Molecular Weight Filgrastim (COLD SHIPMENT REQUIRED) | 0,7 mg |
| USP-1270548 | Fetal Bovine Serum (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 10 mL |
| USP-1544927 | Plastic Additive 1 - Ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl] butanoate] | 100 mg |
| USP-1545067 | Plastic Additive 15 - Epoxidized Soya Oil | 100 mg |
| USP-1548076 | Polyvinyl Chloride | 100 mg |
| USP-1612914 | Sitagliptin System Suitability Mixture - Sitagliptin Phosphate containing about 0.2% of S-enantiomer) | 20 mg |
| USP-1642824 | Tacrolimus 8-epimer (3S,4R,5S,8S,9E,12S,14S,15R,16S,18R,19R,26aS)-8-Allyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone | 15 mg |
| USP-1711029 | Vardenafil System Suitability | 20 mg |
| USP-1727064 | Zolmitriptan Related Compound E - (S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide | 25 mg |
| USP-1448628 | Moxifloxacin Related Compound B (25 mg) - (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) | 25 mg |
| USP-1042437 | Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N8-amino-N2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) (Mixture of epimers) | 20 mg |
| USP-1152814 | Cyclic Olefin Polymer | 1 g |
| USP-1600314 | Regular Bleached Shellac | 100 mg |
| USP-1228530 | Dronedarone Hydrochloride | 125 mg |
| USP-1492200 | Palonosetron Hydrochloride | 100 mg |
| USP-1705334 | Ubiquinol | 5 x 50 mg |
| USP-1005048 | Acetazolamide Related Compound D - (5-Amino-1,3,4-thiadiazole-2-sulfonamide) | 25 mg |
| USP-1005059 | Acetazolamide Related Compound E - (5-Acetamido-1,3,4-thiadiazole-2-sulfonic acid potassium salt) | 25 mg |
| USP-1727097 | Zolmitriptan Related Compound H - (4,4-Diethoxy-N,N-dimethylbutan-1-amine) | 50 mg |
| USP-1035708 | Anhydrotetracycline Hydrochloride - ((4S ,4aS ,12aS )-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide monohydrochloride) | 25 mg |
| USP-1046351 | Azure B - (3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride) | 50 mg |
| USP-1220517 | Dipyridamole Related Compound A - (2,2'-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) | 25 mg |
| USP-1220528 | Dipyridamole Related Compound B - (2,2',2'',2''',2'''',2'''''-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol) | 25 mg |
| USP-1220539 | Dipyridamole Related Compound C - (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) | 25 mg |
| USP-1220540 | Dipyridamole Related Compound D - (2,2'-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol) | 25 mg |
| USP-1220559 | Dipyridamole Related Compound E - (2,2',2'',2'''-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol) | 25 mg |
| USP-1220561 | Dipyridamole Related Compound F - (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol) | 25 mg |
| USP-1225022 | Doxapram Related Compound B - (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one, hydrochloride) | 25 mg |
| USP-1457017 | Naphazoline Related Compound A - (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide) | 30 mg |
| USP-1492255 | Palonosetron Related Compound D - ((3aR)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 15 mg |
| USP-1642835 | Tacrolimus 8-propyl analog (See DETAILS for full Chemical Name) | 15 mg |
| USP-1086152 | Calcipotriene Related Compound C - ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol) | 15 mg |
| USP-1009978 | N-Acetyl-D,L-Methionine (N-Acetylmethionine) | 100 mg |
| USP-1031445 | Amoxapine Related Compound D - (2-Chlorodibenzo[b,f]-[1,4]-oxazepin-11-one) | 50 mg |
| USP-1031478 | Amoxapine Related Compound G - (3-Chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine) | 50 mg |
| USP-1087360 | Calcium Succinate | 200 mg |
| USP-1102941 | Cetirizine Related Compound B - (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride) | 25 mg |
| USP-1102952 | Cetirizine Related Compound C - (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) | 25 mg |
| USP-1152825 | Cyclic Olefin Copolymer (3 strips, 2' x 2' x 1 mm each) | 3 strips |
| USP-1173086 | Desloratadine Related Compound B - (8-chloro-11-(1,2,3,6-tetrahydropyridin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine hydrochloride) | 20 mg |